Pregled bibliografske jedinice broj: 453890
Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? // Spine, 35 (2010), 3; 361-362 doi:10.1097/BRS.0b013e3181cb4651 (međunarodna recenzija, pismo, znanstveni)
CROSBI ID: 453890 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion?
(Re: Hiremath GK, Steinmetz MP, Krishnaney AA. Is it safe to use recombinant human bone morphogenetic protein in posterior cervical fusion? Spine 2009 ; 34:885-9.)
Autori
Čimić, Mislav ; Smoljanović, Tomislav ; Bojanić, Ivan
Izvornik
Spine (0362-2436) 35
(2010), 3;
361-362
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni
Ključne riječi
recombinant human bone morphogenetic protein type 2 ; posterior cervical fusion ; long-term complications ; instrument failure
Sažetak
The authors miscalculated incidence of the long-term complications misleading the readers related to the safety issue of rhBMP-2 use for posterior cervical fusions.
Izvorni jezik
Engleski
POVEZANOST RADA
Projekti:
108-0000000-3652 - Genska terapija mineraliziranih tkiva (Pećina, Marko, MZOS ) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb,
Klinička bolnica "Dubrava",
Klinički bolnički centar Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
